Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Apr;24(1):106-10.
doi: 10.1128/iai.24.1.106-110.1979.

Response of sensitized and unsensitized human lymphocyte subpopulations to Plasmodium falciparum antigens

Response of sensitized and unsensitized human lymphocyte subpopulations to Plasmodium falciparum antigens

D J Wyler et al. Infect Immun. 1979 Apr.

Abstract

Antigen preparations derived from Plasmodium falciparum-infected erythrocytes (but not from uninfected erythrocytes) can stimulate the in vitro proliferation of peripheral blood lymphocytes from malaria-sensitized as well as nonsensitized donors. The possibility that the nonspecific responses might be due to a parasite-derived B-cell mitogen has been previously suggested since polyclonal hypergammaglobulinemia is a frequent accompaniment of malaria infection. To test this hypothesis, we investigated the in vitro proliferative responses of purified T- and B-cell populations to malaria antigens. T but not B cells responded to the antigens. The addition of small numbers of T cells restored the ability of purified B cells to respond to lectin mitogens but not to malaria antigens. Falciparum malaria infection was associated with an increase in T-cell but not in B-cell proliferation in vivo, as assessed by the spontaneous tritiated thymidine incorporation of lymphocytes during a brief incubation in vitro. Our observations suggest that extracts of malaria parasites do not contain a B-cell mitogen but are antigenic as well as mitogenic for T cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Exp Immunol. 1977 Sep;29(3):401-7 - PubMed
    1. J Immunol. 1977 Feb;118(2):478-84 - PubMed
    1. Lancet. 1974 Sep 14;2(7881):609-13 - PubMed
    1. Lancet. 1974 Apr 20;1(7860):742 - PubMed
    1. Lancet. 1974 Mar 16;1(7855):435-6 - PubMed

LinkOut - more resources